Gastric Neuroendocrine Tumors (Carcinoids).

Gastrins / blood Gastroscopy / methods Humans Neuroendocrine Tumors / diagnosis Prognosis Stomach Neoplasms / diagnosis
Gastric carcinoid Hypergastrinemia Netazepide Neuroendocrine tumor (NET)

Journal

Current gastroenterology reports
ISSN: 1534-312X
Titre abrégé: Curr Gastroenterol Rep
Pays: United States
ID NLM: 100888896

Informations de publication

Date de publication:
12 Mar 2019
Historique:
entrez: 15 3 2019
pubmed: 15 3 2019
medline: 3 8 2019
Statut: epublish

Résumé

The diagnosis of gastric neuroendocrine tumors (NETs) is being made with increased frequency likely as a result of more upper endoscopies being done for unrelated reasons. It is therefore vital that gastroenterologists become familiar with the basic work-up and management of patients found to have these tumors. This review describes the classification, pathophysiology, clinical characteristics, and treatment options of the different gastric NETs. In addition to the three traditional subtypes of gastric NETs, additional cases associated with achlorhydria and appropriate hypergastrinemia may exist. The management of gastric NETs between 1 and 2 cm in size remains controversial and needs to be individualized. Gastric NETs are uncommon but are now diagnosed more frequently. This review highlights the role of hypergastrinemia in their development and the controversies around their management.

Identifiants

DOI: 10.1007/s11894-019-0684-7 PMID: 30868284
pubmed: 30868284
doi: 10.1007/s11894-019-0684-7
pii: 10.1007/s11894-019-0684-7
doi:

Substances chimiques

Gastrins 0

Types de publication

Journal Article Review

Langues

eng

Pagination

13

Références

APMIS. 1999 Dec;107(12):1085-92
pubmed: 10660138
N Engl J Med. 2000 Aug 24;343(8):551-4
pubmed: 10954763
Endocr Pathol. 1995 Autumn;6(3):229-237
pubmed: 12114744
Yale J Biol Med. 1992 Nov-Dec;65(6):741-51; discussion 827-9
pubmed: 1341076
Medicine (Baltimore). 2004 Jan;83(1):43-83
pubmed: 14747767
Scand J Gastroenterol. 2004 Jul;39(7):621-8
pubmed: 15370681
Am J Surg Pathol. 2005 Jul;29(7):969-75
pubmed: 15958864
Dig Liver Dis. 2007 Jun;39(6):537-43
pubmed: 17433795
Gastroenterology. 2008 Jun;134(7):1842-60
pubmed: 18474247
Pancreas. 2010 Aug;39(6):707-12
pubmed: 20664470
Endoscopy. 2010 Aug;42(8):664-71
pubmed: 20669078
Ochsner J. 2008 Winter;8(4):191-6
pubmed: 21603501
Clin Gastroenterol Hepatol. 2012 Feb;10(2):126-30
pubmed: 21806955
World J Gastrointest Endosc. 2011 Jul 16;3(7):133-9
pubmed: 21860682
Aliment Pharmacol Ther. 2012 Dec;36(11-12):1067-75
pubmed: 23072686
Gastroenterol Res Pract. 2012;2012:287825
pubmed: 23316222
Case Rep Gastrointest Med. 2013;2013:848075
pubmed: 23401809
Pancreas. 2013 May;42(4):557-77
pubmed: 23591432
Medicine (Baltimore). 2013 May;92(3):135-81
pubmed: 23645327
Ann Gastroenterol. 2013;26(1):29-36
pubmed: 24714698
Clin J Gastroenterol. 2014 Oct;7(5):381-6
pubmed: 26184015
Dig Liver Dis. 2015 Nov;47(11):978-83
pubmed: 26321479
Neuroendocrinology. 2016;103(2):119-24
pubmed: 26784901
Scand J Gastroenterol. 2016 Jul;51(7):767-73
pubmed: 26872579
Am J Surg. 2016 Apr;211(4):778-82
pubmed: 26992358
World J Gastroenterol. 2016 Aug 14;22(30):6817-28
pubmed: 27570419
Br J Clin Pharmacol. 2017 Mar;83(3):466-475
pubmed: 27704617
Surg Clin North Am. 2017 Apr;97(2):333-343
pubmed: 28325190
JAMA Oncol. 2017 Oct 1;3(10):1335-1342
pubmed: 28448665
Arq Bras Cir Dig. 2017 Apr-Jun;30(2):150-154
pubmed: 29257854
Med Oncol. 2018 Aug 4;35(9):123
pubmed: 30078166
Endocrinol Metab Clin North Am. 2018 Sep;47(3):645-660
pubmed: 30098721

Auteurs

Craig R Gluckman (CR)

Division of Gastroenterology and Hepatology, Hospital of the University of Pennsylvania, Perelman School of Medicine, 3400 Civic Center Boulevard, Philadelphia, PA, 19104, USA.

David C Metz (DC)

Division of Gastroenterology and Hepatology, Hospital of the University of Pennsylvania, Perelman School of Medicine, 3400 Civic Center Boulevard, Philadelphia, PA, 19104, USA. David.metz@uphs.upenn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines de tissu nerveux › Neuropeptides › Gastrines › Gastric Neuroendocrine Tumors (Carcinoids).
questionsmedicales.fr › Procédures de chirurgie opératoire › Interventions chirurgicales mini-invasives › Endoscopie › Endoscopie digestive › Endoscopie gastrointestinale › Gastroscopie › Gastric Neuroendocrine Tumors (Carcinoids).
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Gastric Neuroendocrine Tumors (Carcinoids).
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs du tissu nerveux › Tumeurs neuroectodermiques › Tumeurs neuroendocrines › Gastric Neuroendocrine Tumors (Carcinoids).
questionsmedicales.fr › Diagnostic › Pronostic › Gastric Neuroendocrine Tumors (Carcinoids).
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies gastro-intestinales › Maladies de l'estomac › Tumeurs de l'estomac › Gastric Neuroendocrine Tumors (Carcinoids).